Recent Reports

ICER’s review of the comparative clinical effectiveness and value of cognitive and mind-body therapies for treatment of chronic low back and neck pain.

View More on this Topic

ICER’s Draft Evidence Report on treatments for tardive dyskinesia, open to public comment until October 30, 2017. For more information on submitting a public comment, please visit our stakeholder engagement page.

View More on this Topic

ICER’s final report on the clinical effectiveness and value of PARP inihibitors for treatment of ovarian cancer.

View More on this Topic

ICER’s report reviewed evidence on ten abuse-deterrent formulations (ADF) of opioids. Nine of the drugs were extended release (ER) opioids, and one was immediate release (IR). The report assessed evidence on how effectively the drugs reduce abuse of opioids at both the individual patient and population levels.

View More on this Topic

Materials

CTAF

CAR-T Therapy: Research Protocol

CTAF

CAR-T Therapy: Model Analysis Plan

Midwest CEPAC

Cystic Fibrosis: Open Input Period

CTAF

Chronic Low Back and Neck Pain: Meeting Agenda

Midwest CEPAC

Ovarian Cancer: Report-at-a-Glance

Midwest CEPAC

Voretigene Neparvovec: Research Protocol

Midwest CEPAC

Voretigene Neparvovec: Model Analysis Plan

Midwest CEPAC

Ovarian Cancer: Evidence Presentation

Midwest CEPAC

Ovarian Cancer: Model Analysis Plan

Midwest CEPAC

Ovarian Cancer: Research Protocol

Midwest CEPAC

Ovarian Cancer: ICER’s Response to Public Comments

CTAF

Chronic Low Back and Neck Pain: Model Analysis Plan